WeVote
Log In

Bill

Bill

HB 2755

Revenue and taxation; tax credits; biomedical and cancer research; effective date.

2025 Regular Session Introduced by Trey Caldwell

HB 2755 creates Oklahoma tax credits for private biomedical and cancer research investments to drive medical innovation and state competitiveness in the research sector.

Referred to Appropriations and Budget
0
WeVote Research Nonpartisan
Bill Summary · HB 2755

Legislative bill overview

HB 2755 establishes tax credits in Oklahoma to incentivize private investment in biomedical and cancer research activities. The bill aims to support the state's research sector by providing financial relief to businesses and organizations that contribute to these medical research efforts.

Why is this important

Oklahoma currently lacks dedicated tax incentive mechanisms for biomedical research, potentially putting the state at a competitive disadvantage in attracting research facilities and talent compared to other states with established research tax credits. Such credits can stimulate economic development, create high-skilled jobs, and position Oklahoma as a hub for medical innovation while advancing cancer treatment research.

Potential points of contention

  • Revenue impact: Tax credits reduce state revenue; fiscal analysis needed to determine long-term budgetary effects and whether incentives will generate sufficient economic activity to offset losses
  • Definition and scope: Unclear what qualifies as "biomedical and cancer research" and whether credits apply broadly or narrowly, affecting which organizations can claim benefits
  • Accountability mechanisms: Limited public information on oversight standards, reporting requirements, or metrics to measure whether research outcomes justify the public investment

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.